Skip to main content

Published locations for Facial, hand, and foot dermatitis: Lebrikizumab and dupilumab show efficacy in new studies

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Facial, hand, and foot dermatitis: Lebrikizumab and dupilumab show efficacy in new studies

User login

Username

Password

Reset your password

/content/facial-hand-and-foot-dermatitis-lebrikizumab-and-dupilumab-show-efficacy-new-studies
/clinicianreviews/article/262910/atopic-dermatitis/facial-hand-and-foot-dermatitis-lebrikizumab-and
/edermatologynews/article/262910/atopic-dermatitis/facial-hand-and-foot-dermatitis-lebrikizumab-and
/familypracticenews/article/262910/atopic-dermatitis/facial-hand-and-foot-dermatitis-lebrikizumab-and
/fedprac/article/262910/atopic-dermatitis/facial-hand-and-foot-dermatitis-lebrikizumab-and-dupilumab
/internalmedicinenews/article/262910/atopic-dermatitis/facial-hand-and-foot-dermatitis-lebrikizumab
/pediatricnews/article/262910/atopic-dermatitis/facial-hand-and-foot-dermatitis-lebrikizumab-and
/pediatrics/article/262910/atopic-dermatitis/facial-hand-and-foot-dermatitis-lebrikizumab-and
/internalmedicine/article/262910/atopic-dermatitis/facial-hand-and-foot-dermatitis-lebrikizumab-and
/dermatology/article/262910/atopic-dermatitis/facial-hand-and-foot-dermatitis-lebrikizumab-and
/familymedicine/article/262910/atopic-dermatitis/facial-hand-and-foot-dermatitis-lebrikizumab-and